NewAmsterdam Pharma Company N.V. ( NAMS) - Stock Earnings
NAMS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -72.0 million USD | 348000 USD |
| 2025Q4 | -74.9 million USD | 32000 USD |
| 2026Q1 | -48.4 million USD | 3.0 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NAMS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -176.9 million USD | 14.1 million USD |
| 2024 | -241.6 million USD | 45.6 million USD |
| 2025 | -203.8 million USD | 22.5 million USD |
| 2026 Est. | — | — |
NAMS
Price: $30.60
52 week price:
Earnings Per Share: -1.78 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.7 billion